NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Index- P/E- EPS (ttm)-0.24 Insider Own44.23% Shs Outstand14.96M Perf Week-14.76%
Market Cap50.12M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float8.34M Perf Month-33.40%
Enterprise Value45.13M PEG- EPS next Q- Inst Own28.61% Short Float0.82% Perf Quarter-24.04%
Income-3.28M P/S1.22 EPS this Y- Inst Trans235.98% Short Ratio1.37 Perf Half Y33.47%
Sales41.08M P/B1.75 EPS next Y- ROA-4.33% Short Interest0.07M Perf YTD41.35%
Book/sh1.92 P/C3.32 EPS next 5Y- ROE-11.67% 52W High7.25 -53.79% Perf Year120.39%
Cash/sh1.01 P/FCF9.37 EPS past 3/5Y-25.12% -14.93% ROIC-8.46% 52W Low1.04 222.12% Perf 3Y71.79%
Dividend Est.- EV/EBITDA19.97 Sales past 3/5Y1.71% 1.95% Gross Margin72.69% Volatility22.96% 13.33% Perf 5Y-1.18%
Dividend TTM- EV/Sales1.10 EPS Y/Y TTM59.86% Oper. Margin-8.92% ATR (14)0.56 Perf 10Y-51.73%
Dividend Ex-Date- Quick Ratio1.09 Sales Y/Y TTM5.82% Profit Margin-7.98% RSI (14)38.26 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio1.25 EPS Q/Q159.71% SMA20-29.78% Beta-0.41 Target Price9.75
Payout- Debt/Eq0.36 Sales Q/Q37.84% SMA50-31.19% Rel Volume5.89 Prev Close2.60
Employees91 LT Debt/Eq0.35 EarningsMay 06 AMC SMA2002.38% Avg Volume49.68K Price3.35
IPOAug 11, 2009 Option/ShortYes / Yes EPS/Sales Surpr.- - Trades Volume292,855 Change28.85%
Date Action Analyst Rating Change Price Target Change
Nov-12-12Reiterated UBS Neutral $6.50 → $5
Feb-01-11Reiterated UBS Neutral $8 → $6.50
Dec-16-10Downgrade UBS Buy → Neutral $10 → $8
Aug-17-10Reiterated UBS Buy $11 → $10
Aug-17-10Reiterated Morgan Joseph Buy $15 → $10
Aug-17-10Downgrade Jefferies Buy → Hold $13 → $5.50
May-14-10Reiterated Morgan Joseph Buy $21 → $15
Jun-23-25 09:05AM
May-27-25 04:05PM
May-13-25 04:05PM
May-07-25 03:20AM
May-06-25 04:05PM
04:05PM Loading…
Apr-29-25 04:05PM
Mar-19-25 04:05PM
Mar-05-25 07:49AM
02:09AM
Mar-04-25 04:50PM
04:05PM
Feb-25-25 04:05PM
Feb-18-25 07:30AM
Feb-05-25 05:23AM
Feb-04-25 01:31PM
07:30AM Loading…
07:30AM
Dec-10-24 01:39PM
12:08PM
Dec-09-24 04:05PM
Nov-08-24 06:00PM
Nov-07-24 05:09PM
04:05PM
Nov-06-24 05:21PM
Nov-05-24 04:05PM
Oct-31-24 04:05PM
Aug-06-24 05:00PM
04:05PM
Jul-30-24 04:05PM
May-13-24 08:50AM
May-08-24 06:15AM
08:58PM Loading…
May-07-24 08:58PM
05:06PM
04:05PM
Apr-30-24 04:05PM
Apr-02-24 04:05PM
Mar-07-24 11:52AM
Mar-06-24 06:55AM
Mar-05-24 04:26PM
04:05PM
Feb-27-24 04:05PM
Nov-12-23 08:48AM
Nov-07-23 05:10PM
04:05PM
Oct-31-23 04:05PM
Oct-10-23 04:05PM
Aug-08-23 04:33PM
04:05PM
Aug-01-23 04:05PM
Jun-26-23 09:00AM
May-31-23 05:22AM
May-23-23 09:00AM
May-15-23 09:00AM
May-09-23 05:29PM
04:05PM
May-02-23 04:05PM
Apr-17-23 09:52AM
Mar-08-23 07:19AM
Mar-07-23 04:22PM
Feb-28-23 04:05PM
Nov-11-22 06:05AM
Nov-08-22 04:05PM
Nov-01-22 09:20AM
Aug-09-22 04:30PM
04:05PM
Aug-08-22 09:25AM
Aug-02-22 04:05PM
Jul-19-22 09:25AM
May-13-22 12:27PM
May-10-22 04:05PM
May-09-22 09:15AM
May-03-22 04:05PM
Mar-31-22 09:20AM
Mar-08-22 04:05PM
Mar-01-22 04:05PM
Jan-04-22 05:09PM
09:15AM
Dec-01-21 05:06AM
Nov-30-21 11:02AM
05:08AM
Nov-29-21 04:05PM
Nov-16-21 02:27PM
Nov-09-21 04:05PM
Nov-08-21 08:25AM
Nov-02-21 04:05PM
Oct-04-21 08:17AM
Sep-29-21 09:25AM
Aug-10-21 06:15PM
04:05PM
Aug-03-21 04:05PM
03:00PM
Jul-26-21 09:25AM
Jun-22-21 09:15AM
06:46AM
Jun-21-21 09:20AM
08:33AM
Jun-18-21 11:56AM
Jun-17-21 09:40AM
Jun-02-21 12:45PM
May-19-21 03:30PM
May-11-21 04:05PM
Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which focuses on the acquisition, development, and commercialization of branded prescription pharmaceutical products. Its products include Acetadote, Caldolor, Kristalose, Omeclamox, Vaprisol, Vibativ, Sancuso, Boxaban, Vasculan. Dyscorban, and RediTrex. The company was founded by A. J. Kazimi on January 7, 1999 and is headquartered in Nashville, TN.